Stocks · Health care · Pharmaceutical Preparations

AGIOS PHARMACEUTICALS, INC.

AGIO Clue Score43
United States Fiscal year ends December CIK 0001439222 Results filed 5 Nov 2026

What the insiders did Scheduled selling only

Insider
Date
Role
Action
Shares
Price
Amount
Sarah Gheuens
26 Oct 2026
Chief Medical Officer
Sold after exercise
7,866
$37.69
$296.47K
Sarah Gheuens
22 Oct 2026
Chief Medical Officer
Sold after exercise
500
$37.52
$18.76K
Sarah Gheuens
21 Oct 2026
Chief Medical Officer
Sold after exercise
1,489
$37.53
$55.88K

What was left out

Form 4 filings counted 2
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 3
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 9,855
History held since 30 Jul 2013